GATC HEALTH CORP
IRVINE, CA · Founded 2019 · CIK 0001822995 · Biotech · Private
Proprietary AI platform for drug discovery and development acceleration
gatchealth.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $981K
- 6 Form D · Sep 2023
- 37 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 34
- 0 granted · 34 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $100,000 | |
| Private capital raised | Form D · SEC | $20,000 | |
| Private capital raised | Form D · SEC | $10,000,000 | |
| Private capital raised | Form D · SEC | $240,000 | |
| Private capital raised | Form D · SEC | $621,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1609 | Yuva Biosciences, Inc. | — | $1.1M |
| 1610 | CEL-SCI CORPORATION | — | $1.1M |
| 1611 | CELL ORIGINS, LLC | — | — |
| 1612 | GATC HEALTH CORP | — | $981K |
| 1613 | DIVERSE BIOTECH, INC. | — | $669K |
| 1614 | XORTX Therapeutics Inc. | — | $505K |
| 1615 | Stratum Biosciences Inc. | — | $100K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Robert DavidsonDirector
- Gerald DeCiccioExecutive Officer
- Rahul GuptaExecutive Officer
- Uri LitvakDirector
- Dennis LockeDirector · Executive Officer
- Michael ManahanExecutive Officer
- Gerry MartinDirector
- Jeff MosesDirector · Executive Officer
- John StrohDirector · Executive Officer
- Phillip TradDirector
- Jayson UffensDirector · Executive Officer
- Lin YuDirector
Patents
- Prodrugs For Cancer Treatmentapplication
- Methods Of Treating Ptsd And Neurological Disordersapplication
- Biomarkers For Early Detection Of Diabetesapplication
- Personal Wellness Recommendation Engineapplication
- Personal Wellness Recommendation Engineapplication
- System And Methods For Determining Propensity To Opioid Addictionapplication
- Compounds And Methods For Promoting Longevity And Treating Senopathiesapplication
- Formulations And Methods For Treating Dementia And Alzheimer's Diseaseapplication
- Flavonoids For Treating Traumatic Brain Injury And Alzheimer's Diseaseapplication
- System And Methods For Determining Propensity To Post-traumatic Stress Disorder (ptsd)application
- Butyrylcholinesterase (buche) Lateral Flow Assay (lfa) For Determining Elevated Risk Of Sidsapplication
- Digital Twin For Diagnostic And Therapeutic Useapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.